skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What do you make of the most recent earnings announcement and why is the liquidity so thin? I would have thought that after several years of growth and profitability the institutional market would have been interested in picking up some ownership from the tightly owned group. My other question is why would Bennett who appears to own over 63% of the company list it if he is not willing to distribute stock to others, isn't that a very costly venture to list a company public for no other reason that to see its name listed (sarcasm here!)
Read Answer Asked by simon on May 12, 2017
Q: Hey Peter and Co.:
I own the following stocks:
BNS, CCL.B, CNR, CGX, CSU, KXS, GUD, MG, MX, NFI, PPL, PBH, SIS, TOY, SJ, T, WSP, ZCL, VET, BCE, ENGH, TD.

I'm looking for a growth stock to add to my TFSA. I bought SIS for my TFSA last year and it's gone up nearly 100%, so thank you for that! What would you recommend here?
Thanks for all of your great advice over the years. cheers
Andy
Read Answer Asked by Andrew on May 11, 2017
Q: Hi 5i,

Despite the nice QoQ growth at DOL, the debt is also rising drastically. Is this a concern to you? From what I can tell they are essentially issuing debt to buy back stock - at very elevated prices. This can't go on forever? I have a very healthy gain on the DOL shares that I have left and am considering selling all.

Mike
Read Answer Asked by Michael on May 10, 2017
Q: Good day, can you please comment on the latest quarter AT just released? The numbers look great to me. Cheers
Read Answer Asked by Seamus on May 10, 2017
Q: Hi Team, Sorry about just copying this info, but RBC is doing a better job than I could:
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris
Read Answer Asked by Chris on May 08, 2017
Q: Please, Peter: Forward earnings for TMB look exceptionally good, ratings, too. TMB is much more than softwood lumber, including a lot of earnings coming from a specialized pulp (prices up, WTO ruled largely in Canada's favour with China in a tariff dispute)yet TMB has traded in a very NARROW range over the last 3 months or so and continues to do so. OK, TMB is a risk because of high debt... but can you explain the reason for the narrow trading range? I'm thinking it might be a big company like Fairfax, somehow able to buy and sell in a way that affects the price in this way but I don't know anything about how to dig further to get an answer to "why this range"?
Can you help?
Read Answer Asked by Harold on May 02, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!